Deborah Verran - Concepedia

Author

Deborah Verran

Royal Prince Alfred Hospital

Also Known As

DEBORAH VERRAN, Deborah J Verran, Deborah J. Verran, Deborah Jean Verran, Deborah Verran, Dr Deborah Verran

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Royal Prince Alfred Hospital The University of Sydney Children's Hospital at Westmead Centenary Institute University of Alabama at Birmingham

About

Deborah Verran is an author at Royal Prince Alfred Hospital specializing in medicine, transplantation, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	830
2	Emergency Medicine	2	2	34
3	Education	1	1	17
4	Public Health	1	1	85
5	Cardiothoracic Surgery	1	1	15

Deborah Verran

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Extracellular FGF-1 acts as a lens differentiation factor in transgenic mice Michael L. Robinson, Paul A. Overbeek, Deborah Verran, Development	1995	226
Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index Esther L de Graaf, James G. Kench, Pamela Dilworth, Journal of Gastroenterology and Hepatology	2011	163
Chimerism and Tolerance in a Recipient of a Deceased-Donor Liver Transplant Stephen I. Alexander, Neil Smith, Min Hu, New England Journal of Medicine Transplant RejectionOrgan DonationTransplantationHepatologyAutoimmune Disease	2008	158
Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu Geoffrey W. McCaughan, Jenean Spencer, David J. Koorey, Liver Transplantation and Surgery TransplantationHepatologyViral HepatitisLamivudine TherapyImmunology	1999	114
AN ANALYSIS OF LATE DEATHS AFTER LIVER TRANSPLANTATION Sami Asfar, Peter Metrakos, Jonathan P. Fryer, Transplantation Transplant RejectionTransplantationHepatologyAutoimmune DiseaseCardiovascular Disease	1996	113
Infectious Disease Transmission in Solid Organ Transplantation: Donor Evaluation, Recipient Risk, and Outcomes of Transmission S. L. White, William D. Rawlinson, Peter Boan, Transplantation Direct Organ DonationSolid Organ TransplantationTransplantation MedicineDonor EvaluationTransplantation Society	2018	85
CENTRAL PONTINE MYELINOLYSIS AND CYCLOSPORINE NEUROTOXICITY FOLLOWING LIVER TRANSPLANTATION Jonathan P. Fryer, Marielle V. Fortier, Peter Metrakos, Transplantation	1996	78
Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center. Atsushi Nanashima, P Pillay, Michael Crawford, Journal of Hepato-Biliary-Pancreatic Surgery Transplantation SurgeryPostrevascularization SyndromeTransplantationHepatologyOphthalmology	2001	67
Early High Peak Hepatitis C Viral Load Levels Independently Predict Hepatitis C–Related Liver Failure Post–Liver Transplantation Nicholas Shackel, Jade D. Jamias, Wassim Abdul Rahman, Liver Transplantation	2009	52
Long‐term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface‐antigen negative liver transplant recipients from hepatitis B core‐antibody‐positive donors Emilia Prakoso, Simone I. Strasser, David J. Koorey, Clinical Transplantation	2006	49

Page 1